Atazanavir

Description

Atazanavir is an azapeptide HIV-1 protease inhibitor (PI). The compound selectively inhibits the virus-specific processing of viral Gag-Pol proteins in HIV-1 infected cells, thus preventing formation of mature virions and infection of other cells.

Medicine classification

ATC Code
Title
Class
J05AE08
Atazanavir
J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AE Protease inhibitors

Medicines

Drug
Countries
REYATAZ

Australia Austria Canada Cyprus France

Other medications with this active ingredient in combination: EVOTAZ

Product monographs

Monograph
Type
Country
REYATAZ Hard capsules
MPI, EU: SmPC

2D Molecule Structure

2D representation of molecule

Unique Ingredient Identifier (UNII)

QZU4H47A3S - ATAZANAVIR

CAS Registry Number

198904-31-3 - atazanavir

SNOMED-CT

413592000 - Atazanavir (substance)

Usage: Next >